CryoCell International Company Leadership

CCEL Stock  USD 7.40  0.36  5.11%   
CryoCell International employs about 82 people. The company is managed by 5 executives with a total tenure of roughly 65 years, averaging almost 13.0 years of service per executive, having 16.4 employees per reported executive. Inspection of CryoCell International's management performance can provide insight into the company performance.
Mark Portnoy  CEO
Co-CEO and Director
David Portnoy  Chairman
Chairman and Co-CEO
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CryoCell International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
For more information on how to buy CryoCell Stock please use our How to buy in CryoCell Stock guide.

CryoCell International's Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with CryoCell International's future performance. Based on our forecasts, it is anticipated that CryoCell will maintain a workforce of about 80 employees by February 2025.
 
Yuan Drop
 
Covid

CryoCell International Management Team Effectiveness

Return On Equity is expected to rise to 1.04 this year, although the value of Return On Tangible Assets are projected to rise to (0.14). At this time, CryoCell International's Asset Turnover is quite stable compared to the past year. CryoCell International's management efficiency ratios could be used to measure how well CryoCell International manages its routine affairs as well as how well it operates its assets and liabilities.
Common Stock Shares Outstanding is expected to rise to about 7.8 M this year, although the value of Net Income Applicable To Common Shares will most likely fall to about 2.1 M.

CryoCell International Workforce Comparison

CryoCell International is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 223,651. CryoCell International adds roughly 82.0 in number of employees claiming only tiny portion of equities under Health Care industry.

CryoCell International Profit Margins

The company has Profit Margin (PM) of (0.28) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.17 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.17.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.560.66
Fairly Down
Slightly volatile

CryoCell International Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific CryoCell International insiders, such as employees or executives, is commonly permitted as long as it does not rely on CryoCell International's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, CryoCell International insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2024-12-01
1.5
3
2
 25,300 
 20,000 
2022-12-01
1.0833
13
12
 130,691 
 65,974 
2022-09-01
3.0
9
3
 321,958 
 22,500 
2021-12-01
2.6
13
5
 890,600 
 434,447 
2021-09-01
0.5789
11
19
 183,990 
 250,761 
2021-06-01
5.75
23
4
 486,578 
 464,368 
2021-03-01
3.5
14
4
 33,581 
 4,471 
2020-09-01
6.0
48
8
 119,627 
 40,673 
2020-06-01
7.5
30
4
 57,515 
 29,552 
2019-12-01
1.1538
15
13
 150,194 
 357,449 
2019-09-01
10.0
10
1
 161,652 
 20,000 
2018-09-01
4.25
17
4
 97,126 
 60,000 
2018-03-01
2.0
4
2
 211,352 
 21,149 
2017-06-01
0.3333
1
3
 6,000 
 181,780 
2017-03-01
6.0
6
1
 410,543 
 9,281 
2016-09-01
4.0
4
1
 41,063 
 18,563 
2015-09-01
1.5
6
4
 58,100 
 70,000 
2014-03-01
1.2
18
15
 188,113 
 48,317 
2012-09-01
16.0
16
1
 44,603 
 7,500 
2012-06-01
0.75
3
4
 33,562 
 66,499 
2011-12-01
1.5
6
4
 442,500 
 42,500 
2011-09-01
1.0
8
8
 288,000 
 16,000 
2009-09-01
4.0
8
2
 136,251 
 7,708 
2008-09-01
0.875
7
8
 522,500 
 882,314 
2007-09-01
4.5
9
2
 430,030 
 0.00 
2007-06-01
0.6667
2
3
 40,000 
 36,424 
2004-12-01
2.0
2
1
 40,000 
 1,000.00 
2004-09-01
0.1667
1
6
 5,000 
 11,000 
2003-09-01
6.0
6
1
 580,000 
 50,000 

CryoCell International Notable Stakeholders

A CryoCell International stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as CryoCell International often face trade-offs trying to please all of them. CryoCell International's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting CryoCell International's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Mark PortnoyCo-CEO and DirectorProfile
David PortnoyChairman and Co-CEOProfile
Jill TaymansCFO and VP of Fin.Profile
Joanne MDMedical BoardProfile
Oleg MikulinskyChief OfficerProfile

About CryoCell International Management Performance

The success or failure of an entity such as CryoCell International often depends on how effective the management is. CryoCell International management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of CryoCell management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the CryoCell management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.15)(0.14)
Return On Capital Employed(0.27)(0.26)
Return On Assets(0.14)(0.15)
Return On Equity 0.99  1.04 

CryoCell International Workforce Analysis

Traditionally, organizations such as CryoCell International use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare CryoCell International within its industry.

CryoCell International Manpower Efficiency

Return on CryoCell International Manpower

Revenue Per Employee382.2K
Revenue Per Executive6.3M
Net Loss Per Employee116.1K
Net Loss Per Executive1.9M
When determining whether CryoCell International is a strong investment it is important to analyze CryoCell International's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CryoCell International's future performance. For an informed investment choice regarding CryoCell Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CryoCell International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
For more information on how to buy CryoCell Stock please use our How to buy in CryoCell Stock guide.
You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CryoCell International. If investors know CryoCell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CryoCell International listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.625
Earnings Share
(1.07)
Revenue Per Share
3.89
Quarterly Revenue Growth
0.025
Return On Assets
(0)
The market value of CryoCell International is measured differently than its book value, which is the value of CryoCell that is recorded on the company's balance sheet. Investors also form their own opinion of CryoCell International's value that differs from its market value or its book value, called intrinsic value, which is CryoCell International's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CryoCell International's market value can be influenced by many factors that don't directly affect CryoCell International's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CryoCell International's value and its price as these two are different measures arrived at by different means. Investors typically determine if CryoCell International is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CryoCell International's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.